StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of new cell-based treatments, and pharmaceuticals and medical devices. It also engages in cell contract management and transportation business; extraction, purification, processing, storage, testing and sales of biological tissue-derived components; and medical facility operation and management business. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.
Metrics to compare | 7096 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship7096PeersSector | |
|---|---|---|---|---|
P/E Ratio | 42.6x | 14.1x | −0.6x | |
PEG Ratio | −0.81 | 0.02 | 0.00 | |
Price/Book | 3.2x | 1.6x | 2.6x | |
Price / LTM Sales | 3.1x | 0.4x | 3.4x | |
Upside (Analyst Target) | - | 5.7% | 44.4% | |
Fair Value Upside | Unlock | 22.8% | 6.1% | Unlock |